Baillie Gifford & Co’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-360
| Closed | -$14.6K | – | 343 |
|
|
2023
Q1 | $14.6K | Buy |
360
+42
| +13% | +$1.7K | ﹤0.01% | 369 |
|
|
2022
Q4 | $14.8K | Hold |
318
| – | – | ﹤0.01% | 375 |
|
|
2022
Q3 | $16K | Hold |
318
| – | – | ﹤0.01% | 357 |
|
|
2022
Q2 | $15K | Hold |
318
| – | – | ﹤0.01% | 367 |
|
|
2022
Q1 | $23K | Buy |
+318
| New | +$23K | ﹤0.01% | 351 |
|